← Back to Search

N/A

Hematoma Block for Wrist Fractures (Hematoma Block Trial)

N/A
Recruiting
Led By Beatrice Hoffmann, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours after initiation of study procedure
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of two methods of numbing the arm before surgery to fix a broken bone in the wrist.

Who is the study for?
This trial is for adults over 18 who come to the emergency department with a distal radius fracture, which is a type of broken bone near the wrist. It's not specified who can't join, but typically those with additional health complications might be excluded.
What is being tested?
The study aims to compare two methods of pain relief during bone setting: one using an ultrasound guide (a device that helps visualize inside the body) and the traditional method without visual aid.
What are the potential side effects?
While side effects are not detailed here, hematoma blocks generally may cause discomfort at injection site, temporary numbness or tingling in hand, and in rare cases infection or nerve damage.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours after initiation of study procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours after initiation of study procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain Reduction as indicated by Visual Analog Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ultrasound-guided hematoma blockExperimental Treatment1 Intervention
Patients in this arm will receive a bed-side ultrasound guided hematoma block with analgesia (0.25% bupivacaine)
Group II: traditional hematoma blockActive Control1 Intervention
Patients in this arm will have the hematoma block of the distal radius fracture with no ultrasound for guidance with analgesia (0.25% bupivacaine)

Find a Location

Who is running the clinical trial?

Harvard UniversityOTHER
233 Previous Clinical Trials
473,816 Total Patients Enrolled
Beth Israel Deaconess Medical CenterLead Sponsor
855 Previous Clinical Trials
12,930,846 Total Patients Enrolled
Beatrice Hoffmann, MDPrincipal Investigator - Beth Israel Deaconess Medical Center
Beth Israel Deaconess Hospital-Plymouth
Ruprecht-Karl-University (Medical School)
York Hospital (Residency)
~7 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top